Company Filing History:
Years Active: 2016-2018
Title: Innovations of Ryan P McGuinness
Introduction
Ryan P McGuinness is an accomplished inventor based in Tiburon, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein modulation and kinase inhibitors. With a total of 2 patents, his work has advanced the understanding of protein interactions and their implications in drug development.
Latest Patents
One of his latest patents is titled "Methods for identifying modulators of Ras using nonlinear techniques." This patent provides compositions and methods for identifying and detecting modulators of Ras protein conformational states through the use of second harmonic generation (SHG) technology. It also includes methods for detecting conformational changes in the three-dimensional structure of a protein bound to a supported lipid bilayer.
Another significant patent is "Classification of kinase inhibitors using nonlinear optical techniques." This method classifies and distinguishes between type I and type II kinase inhibitors. It employs non-linear optical techniques, particularly second-harmonic generation (SHG), to identify conformational changes in kinase proteins obtained from known type I or type II inhibitors. The method further deduces the manner of binding of unknown inhibitors by comparing them with the signal changes produced by known ligands.
Career Highlights
Ryan currently works at Biodesy, Inc., where he continues to innovate and develop new technologies. His expertise in nonlinear optical techniques has positioned him as a leader in his field. His work has the potential to impact drug discovery and development significantly.
Collaborations
Ryan collaborates with various professionals in the biotechnology sector, including his coworker Joshua S Salafsky. Their combined efforts contribute to the advancement of innovative solutions in protein research.
Conclusion
Ryan P McGuinness is a notable inventor whose work in biotechnology has led to significant advancements in understanding protein interactions and drug development. His contributions through his patents reflect his commitment to innovation in the field.